Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 17, 2025 04:07 ET | Source: Research and Markets

RNA Interference Market Research Report 2024-2034: RNAi-Based Medicines Emerge as Breakthrough Therapy for Cancer, Genetic Disorders and Rare & Infectious Diseases

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "RNA Interference Market by Type, by Application, by End-user, and by Region" report has been added to ResearchAndMarkets.com's offering.The global...
March 07, 2025 05:49 ET | Source: Research and Markets

Oligonucleotide Therapeutics Market Research 2025: Advancements in Genomics Accelerate Development of Targeted Oligonucleotide Drugs - Long-term Forecast to 2035

Dublin, March 07, 2025 (GLOBE NEWSWIRE) -- The "Oligonucleotide Therapeutics Market, Analysis and Forecast: 2025-2035" report has been added to ResearchAndMarkets.com's offering.Technological...
November 19, 2024 10:53 ET | Source: Research and Markets

Antisense and RNAi Therapeutics Market Research Report 2024: Global Market to Reach $3.6 Billion by 2030 - Investments in RNA-Based Research Expands the Market for Novel Therapeutic Approaches

Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) -- The "Antisense and RNAi Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
November 14, 2024 05:21 ET | Source: Research and Markets

North America RNA Therapeutics Market Research 2024-2029: Revolutionary Advancements in RNA Technology and Personalized Medicine Propel Growth

Dublin, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
November 12, 2024 05:33 ET | Source: Research and Markets

Antisense & RNAi Therapeutics Market Overview 2024-2030 - Global Antisense & RNAi Therapeutics Market Forecast to Reach $14.4 Billion by 2030

Dublin, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The "Antisense & RNAi Therapeutics - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for...
August 23, 2024 04:02 ET | Source: Research and Markets

RNAi Market and Technologies Industry Report 2024, with Company Profiles of Major Players including Alnylam Pharmaceuticals, Novartis, Thermo Fisher Scientific and Revvity

Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "RNAi Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market for RNAi technology is estimated to...
May 01, 2024 09:16 ET | Source: Research and Markets

Global RNAi Therapeutics Market Analysis Report 2024-2028: Progress in Collaborations & Associated Deals Bodes Well for the Sector

Dublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Global RNAi Therapeutics Market (By Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19...
April 16, 2024 07:26 ET | Source: Research and Markets

Global Antisense and RNAi Therapeutics Report 2024: A USD 34.7 Billion Predicted Market by 2034, with CAGR of 18% During 2024-2034

Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Global Antisense and RNAi Therapeutics Market" report has been added to ResearchAndMarkets.com's offering.The global antisense and RNAi therapeutics...
February 12, 2024 04:24 ET | Source: Research and Markets

Global RNAi Technology Market Projected to Reach $1.9 Billion by 2028: Precision Medicine Integration Accelerating Personalized Treatments

Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "RNAi Technology Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F" report has been added to ResearchAndMarkets.com's...
January 17, 2024 12:03 ET | Source: Research and Markets

RNAi Therapeutics Market Global Industry Analysis and Forecasts to 2030: A $20.23 Billion Market in 2030, with a CAGR of a 7.69% During 2023-2030

Dublin, Jan. 17, 2024 (GLOBE NEWSWIRE) -- The "RNAi Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030" report has been added to ResearchAndMarkets.com's...

Next Page keyboard_arrow_right